These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10945200)

  • 21. Cost savings impact of a pharmacist-initiated teleservice program for Medicare Part D reviews.
    Massey C; Aungst TD; Evans P; Bartlett D; Silva MA
    J Am Pharm Assoc (2003); 2018; 58(1):56-60. PubMed ID: 29074147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacist-managed medication review in a managed care system.
    Borgsdorf LR; Miano JS; Knapp KK
    Am J Hosp Pharm; 1994 Mar; 51(6):772-7. PubMed ID: 8010315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.
    Tseng CW; Brook RH; Keeler E; Steers WN; Mangione CM
    JAMA; 2004 Aug; 292(8):952-60. PubMed ID: 15328327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic.
    Lobas NH; Lepinski PW; Abramowitz PW
    Am J Hosp Pharm; 1992 Jul; 49(7):1681-8. PubMed ID: 1621723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a medication assistance program with medication therapy management on the health of renal transplant recipients.
    Chisholm MA; Spivey CA; Mulloy LL
    Am J Health Syst Pharm; 2007 Jul; 64(14):1506-12. PubMed ID: 17617501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The estimated costs and savings of medical nutrition therapy: the Medicare population.
    Sheils JF; Rubin R; Stapleton DC
    J Am Diet Assoc; 1999 Apr; 99(4):428-35. PubMed ID: 10207394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating the cost of the Medicare Pharmacist Services Coverage Act of 2001.
    Poole VH; Moran DW; Webb CE
    Pharmacotherapy; 2003 Aug; 23(8):955-65. PubMed ID: 12921241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential impact of pharmacist interventions to reduce cost for Medicare Part D beneficiaries.
    Thatcher EE; Vanwert EM; Erickson SR
    J Pharm Pract; 2013 Jun; 26(3):248-52. PubMed ID: 23178417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacist medication therapy management in home health care: Investigation of a sustainable practice model.
    Corsi K; Lemay V; Orr KK; Cohen L
    J Am Pharm Assoc (2003); 2018; 58(4S):S64-S68. PubMed ID: 29887258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant.
    Yen EF; Hardinger K; Brennan DC; Woodward RS; Desai NM; Crippin JS; Gage BF; Schnitzler MA
    Am J Transplant; 2004 Oct; 4(10):1703-8. PubMed ID: 15367228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementing the Medicare drug benefit in a diverse inner-city community.
    Stubbings J; Durley SF; Lin SJ; Kliethermes M; Aruru MD; Evangelista C; Byun M
    Am J Health Syst Pharm; 2007 Jan; 64(2):193-9. PubMed ID: 17215471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic evaluations of pharmacist-managed services in people with diabetes mellitus: a systematic review.
    Wang Y; Yeo QQ; Ko Y
    Diabet Med; 2016 Apr; 33(4):421-7. PubMed ID: 26433008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A benefit-cost analysis of family planning services in Iowa.
    Levey LM; Nyman JA; Haugaard J
    Eval Health Prof; 1988 Dec; 11(4):403-24. PubMed ID: 10312809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of a comprehensive pharmaceutical care program for an underserved population.
    Mascardo LA; Spading KA; Abramowitz PW
    Am J Health Syst Pharm; 2012 Jul; 69(14):1225-30. PubMed ID: 22761077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing medication use with a pharmacist-provided comprehensive medication management service for patients with psychiatric disorders.
    Cobb CD
    Pharmacotherapy; 2014 Dec; 34(12):1336-40. PubMed ID: 25329409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Financial implications of pharmacist-led Medicare annual wellness visits.
    Park I; Sutherland SE; Ray L; Wilson CG
    J Am Pharm Assoc (2003); 2014; 54(4):435-40. PubMed ID: 25063264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.
    Rosen AB; Hamel MB; Weinstein MC; Cutler DM; Fendrick AM; Vijan S
    Ann Intern Med; 2005 Jul; 143(2):89-99. PubMed ID: 16027450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a pharmacist-run call center on medication access for ambulatory care patients.
    Bartlett D; Evans P; Sullivan M
    Am J Health Syst Pharm; 2009 Sep; 66(18):1666-8. PubMed ID: 19729572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.